EP3012255
STÖÐUGT KRISTALSFORM TIPIRACIL HÝDRÓKLÓRÍÐS OG KRISTALLAMYNDUNARAÐFERÐ FYRIR SAMA EFNI
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
17.6.2014EP published:
13.10.2021EP application number:
14814354.8
EP translation filed:
7.12.2021Grant published:
15.1.2022EPO information:
European Patent Register
Max expiry date:
16.6.2034Expiry date:
16.6.2026Next due date:
30.6.2026
Title:
STABLE CRYSTAL FORM OF TIPIRACIL HYDROCHLORIDE AND CRYSTALLIZATION METHOD FOR THE SAME
Timeline
Today
17.6.2014EP application
13.10.2021EP Publication
7.12.2021Translation submitted
15.1.2022Registration published
16.6.2026Expires
Owner
Name:
Taiho Pharmaceutical Co., Ltd.Address:
1-27 Kandanishiki-cho, Chiyoda-ku Tokyo 101-8444, JP
Inventor
Name:
KAZUNO, HidekiAddress:
Tsukuba-shi Ibaraki 300-2611, JP
Name:
MUTSUMI, TomonobuAddress:
Kodama-gun Saitama 3670241, JP
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
2013126567Date:
17.6.2013Country:
JP
Classification
Categories:
C07D 403/06, A61K 31/506, A61K 31/7072, A61P 35/00, A61P 43/00
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 6.5.2022
Expires: 16.6.2023
Payer: Árnason Faktor ehf.
Number: 10
Paid: 24.5.2023
Expires: 16.6.2024
Payer: Árnason Faktor ehf.
Number: 11
Paid: 7.5.2024
Expires: 16.6.2025
Payer: Árnason Faktor ehf.
Number: 12
Paid: 2.6.2025
Expires: 16.6.2026
Payer: Árnason Faktor ehf.